A British company is seeding genetically modified flies with human tumors, giving patients their own personal drug trials.
Joel Silverman is facing down a nightmarish cancer prognosis. What he’d thought was a benign cyst in his jaw was actually a rare cancer that grew stealthily, supplanting the bone. And even after the tumor was excised, an undetectable remnant in his bloodstream seeded metastatic lesions in his lungs. His doctors can do little beyond removing the lesions as they appear. This cancer, myoepithelial carcinoma, doesn’t have a standard chemotherapy treatment.
Silverman, 59, an internal medicine physician in Boca Raton, Florida, is accustomed to delivering both good news and
→ Continue reading at Wired - Science